Avrio Fund III Closes Its Sixth Investment
June 18, 2017
Avrio Capital and POS Bio-Sciences Inc. partner to drive Agri-Food tech commercialization model
SASKATOON and CALGARY, June 18th, 2017 /CNW/ – Avrio Capital Inc. (“Avrio”) is pleased to announce that it has completed its sixth investment, closing an investment with POS Bio-Sciences Inc. (“POS”). Based in Saskatoon, SK, POS is a global leader in the creation of value-added products from biological-based raw materials — providing R&D, custom processing, and analytical services to clients on six continents. Having operated since 1977, the Company has worked closely with entrepreneurs, multi-national corporations and governments in providing innovative solutions in processing and extracting complex proteins, oils, starches and bioactive components from various forms of biomass. Avrio is one of Canada’s longest standing venture franchises having accumulated 15 years of investment experience in food and agricultural technology.
“We are thrilled to be partnering with POS in driving the transition from a predominantly research focused organization to a product-focused platform built on 40 years of expertise in processing and isolating compounds and molecules of interest from various biomass sources.” said Steven Leakos, Managing Director at Avrio. “As we continue into the next phase of our development, we feel very fortunate to have attracted Avrio to assist in turning our overall business model towards a truly commercial enterprise. We are excited to have added the Avrio representatives to our commercialization advisory committee to drive the transformation of our Company in an efficient and profitable manner.” commented Dale Kelly, CEO of POS.
The investment focus of Fund III remains in the agriculture and food technology sectors, where the firm has posted industry leading results with investments in companies such as Brookside, and Wolf Trax Inc., transactions that were selected as the Canadian Venture Capital Association’s Deal of the Year for generating outstanding investment returns.
Avrio has now concluded six investments out of its third fund, which closed with total commitments approaching $110M in May of 2016. The fund is actively seeking quality opportunities to deploy $2-$10M in dynamic, growing agricultural and food technology companies seeking growth or expansion capital to address global issues related to health, wellness and sustainability.
About Avrio Capital Inc.
The Avrio group of entities was established in 2002 to identify and invest in innovative food and agriculture companies that provide solutions to global challenges in the areas of health, wellness and sustainability. As the global pioneer in ag and food technology investing, the team has been a very active investor in the space for almost 15 years, having completed over fifty investments since its inception. Avrio is a highly engaged investor, working closely alongside of their portfolio companies to provide the support and resources needed to transform emerging companies into global leaders.
About POS Bio-Sciences Inc.
POS Bio-Sciences is an innovative R & D bioprocessing company that customizes inventive answers for clients across the global market place. POS creates value added products and ingredients from biological materials of all kinds, for uses in food supplements, nutraceuticals, cosmetics, biofuels, and medical devices. POS supports those who desire sustainable and profitable products and processes. This competitive position is based on employee-ownership and with employees having a vested interest in providing the very best in value and customer service. POS’s head office is located in Saskatoon, Saskatchewan, Canada.
SOURCE: Avrio Capital
For further information: Media Contact: Randi Lethebe, Rlethebe@avriocapital.com, 403.215.5492, www.avriocapital.com